European Archives of Oto-Rhino-Laryngology

, Volume 269, Issue 9, pp 2021–2026 | Cite as

Can vaccination against pneumococci prevent otitis media with effusion?

  • Aly M. N. El-MakhzangyEmail author
  • Naema M. Ismail
  • Salma B. Galal
  • Tamer S. Sobhy
  • Amal A. Hegazy
Review Article


The most common cause of hearing loss in early childhood is otitis media with effusion (OME). Prevention of OME in preschool children will improve quality of life. The authors aimed to determine, by the best available published evidence, whether vaccination against pneumococci effectively prevents OME. The study design was based on systematic review (SR) of randomized controlled trials (Level 1a evidence). The medical literature available through searching Medline database was reviewed using the following keywords “Otitis media with effusion,” “secretory otitis media,” or “glue ear,” and “vaccination” limiting the search to randomized controlled trials (RCTs) conducted on children (0–18 years), published in English, in the last 10 years. Results of effects of vaccination on prevention of OME from the included RCTs were utilized to conduct a meta-analysis to find out the preventive value of antipneumococcal vaccination. Three RCTs were identified conforming to the inclusion criteria. Meta-analysis of results showed no significant preventive advantage for antipneumococcal vaccination. Based on the results it was confirmed that neither primary nor secondary prevention by antipneumococcal vaccination has a beneficial impact on OME. More RCTs should be conducted to study the effect of vaccination on OME. Level of evidence: 1a, Systematic Review of Randomized Controlled Trials.


Otitis media with effusion Secretory otitis Glue ear Pneumococcal vaccination Immunization 


Conflict of interest



  1. 1.
    Senturia BH, Bluestone CD, Klein JO, Lim DJ, Paradise JL (1980) Report of the ad hoc committee on definition and classification on otitis media and otitis media with effusion. Ann Otol Rhinol Laryngol 89(68):3–4Google Scholar
  2. 2.
    Blustone CD, Beery QC, Andrus S (1974) Mechanics of the eustachian tube as it influences susceptibility to and persistence of middle ear effusions in children. Ann Otol Rhinol Laryngol 83(11):27–34Google Scholar
  3. 3.
    Stenfors L-E, Räisänen S (1988) Quantification of bacteria in middle ear effusions. Acta Otolaryngol (Stockh.) 106:435–440CrossRefGoogle Scholar
  4. 4.
    Keles E, Bulut Y, Kaygusuz I, Karlidag T, Yalçin S, Özdarendeli A, Cengiz-Alpay H (2005) Identification of Chlamydia trachomatis with polymerase chain reactionin middle ear fluid in otitis media with effusion. Indian Pediatr 42:686–691PubMedGoogle Scholar
  5. 5.
    Hurst DS, Venge P (2002) The impact of atopy on neutrophil activity in middle ear effusion from children and adults with chronic otitis media. Arch Otolaryngol Head Neck Surg 128:561–566PubMedGoogle Scholar
  6. 6.
    Rosenfeld RM, Culpepper L, Doyle KJ et al (2004) Clinical practice guideline: otitis media with effusion. Otolaryngol Head Neck Surg 130(Suppl):S95–S118PubMedCrossRefGoogle Scholar
  7. 7.
    Roberts JE, Rosenfeld RM, Zeisel SA (2004) Otitis media and speech and language: a meta-analysis of prospective studies. Pediatrics 113:e238–e248PubMedCrossRefGoogle Scholar
  8. 8.
    AAFP, AAO-HNS, AAP Subcommittee on Otitis Media with Effusion (2004) Otitis media with effusion. Pediatrics 113:1412–1429CrossRefGoogle Scholar
  9. 9.
    Pletz MW, Maus U, Krug N, Welte T, Lode H (2008) Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 32:199–206PubMedCrossRefGoogle Scholar
  10. 10.
    The Cochrane Collaboration (2008) Review Manager (RevMan) [Computer program]. Version 5.0. The Nordic Cochrane Centre, CopenhagenGoogle Scholar
  11. 11.
    Bergen R, Black S, Shinefield H et al (2004) Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 23(2):138–144PubMedCrossRefGoogle Scholar
  12. 12.
    Marchisio P, Cavagna R, Maspes B et al (2002) Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 35(2):168–174PubMedCrossRefGoogle Scholar
  13. 13.
    van Heerbeek N, Straetemans M, Wiertsema SP et al (2006) Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion. Pediatrics 117(3):603–608PubMedCrossRefGoogle Scholar
  14. 14.
    Straetemans M, Palmu A, Auranen K, Zielhuis GA, Kilpi T (2003) The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age. Int J Pediatr Otorhinolaryngol 67(11):1235–1242PubMedCrossRefGoogle Scholar
  15. 15.
    Le TM, Rovers MM, Veenhoven RH, Sanders EA, Schilder AG (2007) Effect of pneumococcal vaccination on otitis media with effusion in children older than 1 year. Eur J Pediatr 166(10):1049–1052PubMedCrossRefGoogle Scholar
  16. 16.
    Kiliç R, Safak MA, Ozdek A, Göçmen H, Kiliç D, Samim E (2002) Effect of 23 valent pneumococcal polysaccharide and Haemophilus influenza conjugated vaccines on the clinical course of otitis media with effusion. Laryngoscope 112:2042–2045PubMedCrossRefGoogle Scholar
  17. 17.
    Poehling KA, Szilagyi PG, Grijalva CG et al (2007) Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 119:707–715PubMedCrossRefGoogle Scholar
  18. 18.
    Eskola J, Kilpi T, Palmu A et al (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344(6):403–409PubMedCrossRefGoogle Scholar
  19. 19.
    Veenhoven R, Bogaert D, Uiterwaal C et al (2003) Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361:2189–2195PubMedCrossRefGoogle Scholar
  20. 20.
    Engel J, Anteunis L, Volovics A, Hendriks J, Marres E (1999) Prevalence rates of otitis media with effusion from 0 to 2 years of age: healthy-born versus high-risk-born infants. Int J Pediatr Otorhinolaryngol 47:243–251PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Aly M. N. El-Makhzangy
    • 1
    Email author
  • Naema M. Ismail
    • 2
  • Salma B. Galal
    • 3
  • Tamer S. Sobhy
    • 4
  • Amal A. Hegazy
    • 5
    • 6
  1. 1.Otorhinolaryngolgy Department, Faculty of MedicineAin Shams UniversityCairoEgypt
  2. 2.Audiology Unit, Otorhinolaryngology Department, Faculty of MedicineAl-Azhar UniversityCairoEgypt
  3. 3.WHOGenevaSwitzerland
  4. 4.Otorhinolaryngolgy Department, Faculty of MedicineAin Shams UniversityCairoEgypt
  5. 5.Community and Industrial Medicine DepartmentAl-Azhar UniversityCairoEgypt
  6. 6.King Abdul Aziz UniversityJeddahKingdom of Saudi Arabia

Personalised recommendations